Suita, Japan

Mari Itoh

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1999-2003.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1999-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mari Itoh: Innovator in Medicinal Chemistry

Introduction

Mari Itoh is a prominent inventor based in Suita, Japan. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of pharmaceutical compounds. With a total of 3 patents to her name, Itoh continues to push the boundaries of science and medicine.

Latest Patents

Among her latest patents are notable inventions such as the compound 5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino acetamide derivatives. This patent also includes the process for producing these compounds, as well as medicinal compositions containing them. Additionally, she has developed 2,3-disubstituted pyridine derivatives, which encompass processes for their preparation, drug compositions containing these derivatives, and intermediates for their preparation.

Career Highlights

Mari Itoh is currently associated with Dainippon Pharmaceutical Company, Limited, where she applies her expertise in medicinal chemistry to develop innovative drug solutions. Her work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Throughout her career, Itoh has collaborated with esteemed colleagues, including Teruya Murata and Shunya Nakamura. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mari Itoh stands out as a dedicated inventor in the field of medicinal chemistry, with a focus on developing innovative pharmaceutical compounds. Her contributions continue to impact the industry positively, showcasing her commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…